New prototype project under mtec consortium titled in-007: an inhaled ACE2 targeting therapeutic prototype for pandemic preparedness this proposal was submitted under request for project proposals…
Ended Awarded Last action
- Contract number
- HT94252390017
- Awardee
-
Medical Technology Enterprise Consortium UEI RTGVVL7F6J11
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $6,450,918
Award facts
- Contract value 100% obligated
- $6,450,918.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Summerville, SC 29486, USA
- Primary consortia member
- Inhalon Biopharma, Inc.
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $700,785 | |
| Original award | $5,750,133 |
About this award
This federal contract award, valued at $6,450,918.48, was made by the Defense Health Agency (DHA) to the Medical Technology Enterprise Consortium (MTEC), a nonprofit organization that serves as a medical technology accelerator for the Department of Defense. The contract is for a new prototype project under the MTEC consortium titled "In-007: An Inhaled ACE2 Targeting Therapeutic Prototype for Pandemic Preparedness" which was submitted in response to Request for Project Proposals Number MTEC-22-02-MPAI-009. The contract has an ultimate completion date of February 6, 2026 and is classified as an Other Transaction Order with an "Other" pricing type. There is no set-aside designation for this award. This contract award is associated with MTEC's larger Other Transaction Indefinite Delivery Vehicle (IDV) agreement with the DHA, valued at $3,466,511.50, which enables the consortium to rapidly prototype and field innovative medical products across various domains, including traumatic brain injury solutions, regenerative medicine, infectious disease diagnostics, and more, in support of the Department of Defense's medical technology priorities and readiness missions.
Description
New prototype project under mtec consortium titled in-007: an inhaled ACE2 targeting therapeutic prototype for pandemic preparedness this proposal was submitted under request for project proposals number mtec-22-02-mpai-009
Quick answers
Who was awarded contract HT94252390017?
HT94252390017 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on August 15, 2023.
How much is contract HT94252390017 worth?
The government has obligated $6,450,918 on HT94252390017.
Is contract HT94252390017 an order under another contract?
Yes. HT94252390017 is an other transaction order under W81XWH1590001, an other transaction IDV.
Was contract HT94252390017 competed?
The extent of competition for HT94252390017 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award